BMY

Bristol-Myers Squibb Company (BMY) nnounces Positive Top-Line Results from Registrational Phase 2 Study of Luspatercept in Adults with Alpha (α)-Thalassemia

4 weeks ago

Bristol-Myers Squibb Company (NYSE: BMY) FY 2026 Other Release

1 month ago

Bristol-Myers Squibb Company (NYSE: BMY) FY 2026 Other Release

1 month ago

Bristol-Myers Squibb Company (NYSE: BMY) Sec Form 10K

1 month ago

Bristol-Myers Squibb Company (NYSE: BMY) Sec Form 8K

2 months ago

Bristol-Myers Squibb Company (NYSE: BMY) Q2 2025 Earnings Call dated Jul. 31, 2025 Corporate Participants: Charles E Triano — Senior…

2 months ago

Bristol-Myers Squibb Company (NYSE: BMY) Q3 2025 Earnings Call dated Oct. 30, 2025 Corporate Participants: Chuck Triano — Senior Vice…

5 months ago

Bristol Myers Squibb (NYSE: BMY) reported its third quarter 2025 earnings results today. Revenues increased 3% year-over-year to $12.2 billion.…

8 months ago

Bristol Myers Squibb (NYSE: BMY) reported its second quarter 2025 earnings results today. Total revenues inched up 1% year-over-year to…

1 year ago

Bristol Myers Squibb (NYSE: BMY) reported its third quarter 2024 earnings results today. Total revenues increased 8% year-over-year to $11.9…

2 years ago

Bristol Myers Squibb (NYSE: BMY) reported first quarter 2024 earnings results today. Total revenues increased 5% year-over-year to $11.9 billion.…